W
Wolfgang Lilleby
Researcher at Oslo University Hospital
Publications - 86
Citations - 1615
Wolfgang Lilleby is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Prostate cancer & Radiation therapy. The author has an hindex of 20, co-authored 74 publications receiving 1338 citations. Previous affiliations of Wolfgang Lilleby include Rikshospitalet–Radiumhospitalet & University of Oslo.
Papers
More filters
Journal ArticleDOI
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
Amar U. Kishan,Ryan Cook,Jay P. Ciezki,Ashley E. Ross,Mark Pomerantz,Paul L. Nguyen,Talha Shaikh,Phuoc T. Tran,Kiri A. Sandler,Richard G. Stock,Gregory S. Merrick,D. Jeffrey Demanes,Daniel E. Spratt,Eyad Abu-Isa,Trude B. Wedde,Wolfgang Lilleby,Daniel J. Krauss,Grace Shaw,Ridwan Alam,Chandana A. Reddy,Andrew J. Stephenson,Eric A. Klein,Danny Y. Song,Jeffrey J. Tosoian,John V. Hegde,Sun Mi Yoo,Ryan Fiano,Anthony V. D'Amico,Nicholas G. Nickols,Nicholas G. Nickols,William J. Aronson,Ahmad Sadeghi,Stephen Greco,Curtiland Deville,Todd McNutt,Theodore L. DeWeese,Robert E. Reiter,J. Said,Michael L. Steinberg,Eric M. Horwitz,Patrick A. Kupelian,Patrick A. Kupelian,Christopher R. King +42 more
TL;DR: Among patients with Gleason score 9-10 prostate cancer, treatment with EBRT+BT with androgen deprivation therapy was associated with significantly better prostate cancer–specific mortality and longer time to distant metastasis.
Journal ArticleDOI
Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy
TL;DR: In spite of considerable malignancy and/or treatment-related morbidity QoL was good or only slightly impaired in the majority of patients with localized prostate cancer who presented with stable disease > 1 year after definitive radiotherapy or radical prostatectomy with no difference as compared to the age-matched normal population.
Journal ArticleDOI
Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy.
Tormod S. Nilsen,Truls Raastad,Eva Skovlund,Kerry S. Courneya,Carl W. Langberg,Wolfgang Lilleby,Sophie D. Fosså,Lene Thorsen +7 more
TL;DR: In summary, high-load strength training improved LBM in extremities and physical functioning, but had no effect on fat mass, aBMD, or HRQOL in PCa patients on ADT.
Journal ArticleDOI
Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer.
Wolfgang Lilleby,Gustav Gaudernack,Paal Brunsvig,Ljiljana Vlatkovic,Melanie Schulz,Kate Mills,Knut Håkon Hole,Else Marit Inderberg +7 more
TL;DR: Treatment with UV1 and GM-CSF gave few adverse events and induced specific immune responses in a large proportion of patients unselected for HLA type, warranting further clinical studies in mPC.
Journal ArticleDOI
Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA
Ingvild Paur,Wolfgang Lilleby,Siv Kjølsrud Bøhn,Erik Hulander,Willibrord Klein,Ljiljana Vlatkovic,Karol Axcrona,Karol Axcrona,Nils Bolstad,Trine Bjøro,Trine Bjøro,Petter Laake,Kristin Austlid Taskén,Kristin Austlid Taskén,Aud Svindland,Lars M. Eri,Bjørn Brennhovd,Monica Hauger Carlsen,Sophie D. Fosså,Sigbjørn Smeland,Anette Karlsen,Rune Blomhoff,Rune Blomhoff +22 more
TL;DR: Three week nutritional interventions with tomato-products alone or in combination with selenium and n-3 fatty acids lower PSA in patients with non-metastatic prostate cancer, suggesting that the effect may depend on both aggressiveness of the disease and the blood levels of lycopene, selenIUM and omega- 3 fatty acids.